Event Details
January 01, 2017
Description
AAN 2017 Presentation
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| ARM | organization | 125 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024906.jpg
This document is page 90 of a Cowen equity research report dated February 25, 2019, analyzing the clinical trial results (GWPCARE3) for GW Pharma's drug Epidiolex. It contains statistical data, bar charts, and a safety table regarding seizure reduction and adverse effects. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to the US House Oversight Committee, likely regarding financial records or communications involving the recipient or related parties.
Related Events
Events with shared participants
Planned attack date by al Qaeda (per flier); actual deployment of Egyptian 2nd Army troops to el-Arish.
0012-08-01 • el-Arish, Sinai
Launch of programme for the acquisition of 72 Typhoon aircraft and modernization of Saudi Armed Forces.
2007-01-01 • Saudi Arabia
GW announced that Epidiolex's second Phase III pivotal trial (GWPCARE3) in the treatment of Lennox-Gastaut syndrome was also successful.
2016-09-01 • N/A
32 million worth of digital currency ether stolen by hackers
2017-07-20 • Online
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event